Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
RAR-related orphan receptor gamma | 13 | 0 | 0 | 13 |
ATAD5 protein, partial | 3 | 0 | 0 | 3 |
GLS protein | 8 | 0 | 0 | 8 |
Microtubule-associated protein tau | 11 | 0 | 0 | 11 |
Smad3 | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 12 | 0 | 0 | 12 |
thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
nuclear receptor subfamily 1, group I, member 3 | 11 | 0 | 0 | 11 |
progesterone receptor | 9 | 0 | 0 | 9 |
EWS/FLI fusion protein | 4 | 0 | 0 | 4 |
retinoic acid nuclear receptor alpha variant 1 | 11 | 0 | 0 | 11 |
retinoid X nuclear receptor alpha | 9 | 0 | 0 | 9 |
estrogen-related nuclear receptor alpha | 16 | 0 | 0 | 16 |
estrogen nuclear receptor alpha | 19 | 0 | 0 | 19 |
peroxisome proliferator activated receptor gamma | 9 | 0 | 0 | 9 |
aryl hydrocarbon receptor | 4 | 0 | 0 | 4 |
chromobox protein homolog 1 | 11 | 0 | 0 | 11 |
thyroid hormone receptor beta isoform 2 | 12 | 0 | 0 | 12 |
peripheral myelin protein 22 | 11 | 0 | 0 | 11 |
cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit pi | 5 | 3 | 1 | 9 |
ATP-binding cassette sub-family C member 3 | 0 | 13 | 0 | 13 |
Multidrug resistance-associated protein 4 | 0 | 13 | 0 | 14 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Voltage-dependent calcium channel gamma-2 subunit | 5 | 0 | 0 | 5 |
Bile salt export pump | 0 | 18 | 0 | 18 |
Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 6 | 0 | 6 |
Carbonic anhydrase 2 | 0 | 6 | 0 | 6 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 1 | 2 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 4 | 1 | 6 |
Cytochrome P450 2D6 | 0 | 5 | 0 | 5 |
Cytochrome P450 2C9 | 0 | 6 | 0 | 6 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 3 | 1 | 9 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 5 | 3 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 3 | 1 | 9 |
UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
Glutamate receptor 2 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 3 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 3 | 1 | 9 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 4 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 3 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 3 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 3 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 3 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 3 | 1 | 9 |
Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
Nuclear receptor ROR-gamma | 6 | 0 | 0 | 6 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 3 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 3 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 3 | 1 | 9 |
Carbonic anhydrase 9 | 0 | 3 | 0 | 3 |
GABA theta subunit | 5 | 3 | 1 | 9 |
Canalicular multispecific organic anion transporter 1 | 0 | 12 | 0 | 12 |
Carbonic anhydrase 15 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 13 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 5 | 3 | 1 | 9 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 2 |
toxin B | 0 | 0 | 0 | 1 |
Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
Chain A, Cruzipain | 3 | 0 | 0 | 3 |
interleukin 8 | 5 | 0 | 0 | 5 |
phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
glucocorticoid receptor [Homo sapiens] | 11 | 0 | 0 | 11 |
farnesoid X nuclear receptor | 6 | 0 | 0 | 6 |
peroxisome proliferator-activated receptor delta | 10 | 0 | 0 | 10 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 14 | 0 | 0 | 14 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 5 | 0 | 0 | 5 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 18 | 0 | 0 | 18 |
lamin isoform A-delta10 | 16 | 0 | 0 | 16 |
Cytochrome P450 2C19 | 0 | 5 | 0 | 6 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 7 | 0 | 7 |
Aurora kinase B | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
thioredoxin reductase | 8 | 0 | 0 | 8 |
TDP1 protein | 14 | 0 | 0 | 14 |
arylsulfatase A | 3 | 0 | 0 | 3 |
euchromatic histone-lysine N-methyltransferase 2 | 11 | 0 | 0 | 11 |
Bloom syndrome protein isoform 1 | 5 | 0 | 0 | 5 |
D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 6 | 0 | 0 | 6 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 5 | 0 | 0 | 5 |
Chain A, 2-oxoglutarate Oxygenase | 5 | 0 | 0 | 5 |
USP1 protein, partial | 6 | 0 | 0 | 6 |
DNA polymerase kappa isoform 1 | 4 | 0 | 0 | 4 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
Caspase-7 | 2 | 0 | 0 | 2 |
Inositol monophosphatase 1 | 4 | 0 | 0 | 4 |
Solute carrier organic anion transporter family member 1B3 | 0 | 6 | 0 | 8 |
Solute carrier organic anion transporter family member 1B1 | 0 | 4 | 0 | 6 |
AR protein | 19 | 0 | 0 | 19 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
Cellular tumor antigen p53 | 8 | 0 | 0 | 8 |
Potassium channel subfamily K member 3 | 0 | 3 | 0 | 3 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Luciferase | 6 | 0 | 0 | 6 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
GALC protein | 4 | 0 | 0 | 4 |
GLI family zinc finger 3 | 15 | 0 | 0 | 15 |
Thrombopoietin | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
pregnane X nuclear receptor | 11 | 0 | 0 | 11 |
bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
caspase-3 | 2 | 0 | 0 | 2 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 8 | 0 | 0 | 8 |
activating transcription factor 6 | 3 | 0 | 0 | 3 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 5 | 0 | 0 | 5 |
Histone H2A.x | 7 | 0 | 0 | 7 |
peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
potassium voltage-gated channel subfamily H member 2 isoform d | 5 | 0 | 0 | 5 |
FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
geminin | 12 | 0 | 0 | 12 |
survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
Spike glycoprotein | 7 | 0 | 0 | 7 |
ATPase family AAA domain-containing protein 5 | 5 | 0 | 0 | 5 |
Ataxin-2 | 6 | 0 | 0 | 6 |
ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Hsf1 protein | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid | 0 | 2 | 0 | 2 |
glp-1 receptor, partial | 6 | 0 | 0 | 6 |
estrogen receptor 2 (ER beta) | 6 | 0 | 0 | 6 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 7 | 0 | 0 | 7 |
G | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 4 | 0 | 4 |
Interferon beta | 8 | 0 | 0 | 8 |
HLA class I histocompatibility antigen, B alpha chain | 7 | 0 | 0 | 7 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
Albumin | 0 | 0 | 2 | 3 |
Albumin | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 2 | 5 |
Translocator protein | 0 | 1 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 1A | 0 | 5 | 1 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 3 | 1 | 4 |
Translocator protein | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 3 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 4 | 0 | 4 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 4 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 3 | 0 | 3 |
cytochrome P450 2C9, partial | 7 | 0 | 0 | 7 |
Chain A, Sex Hormone-Binding Globulin | 0 | 0 | 1 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 5 | 0 | 0 | 5 |
transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
Plasma kallikrein | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 3 | 0 | 4 |
Sex hormone-binding globulin | 0 | 1 | 2 | 3 |
Progesterone receptor | 0 | 1 | 0 | 1 |
Progesterone receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 1 | 0 | 1 |
Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Sex hormone-binding globulin | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 2 | 2 | 6 |
Aromatase | 0 | 1 | 0 | 2 |
Androgen receptor | 0 | 7 | 1 | 8 |
Androgen receptor | 0 | 1 | 1 | 2 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 0 | 1 | 1 |
Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
Neuropeptide FF receptor 2 | 0 | 0 | 0 | 1 |
ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
SMAD family member 2 | 5 | 0 | 0 | 5 |
SMAD family member 3 | 5 | 0 | 0 | 5 |
mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 2 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 2 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 2 | 0 | 2 |
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 4 | 0 | 0 | 4 |
Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
glucocerebrosidase | 4 | 0 | 0 | 4 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Thymidylate synthase | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Alpha-synuclein | 1 | 1 | 0 | 2 |
Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 1 |
Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
Multidrug resistance associated protein | 0 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 5 | 0 | 0 | 5 |
Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 | 5 | 0 | 0 | 5 |
Snq2p | 0 | 0 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 4 | 0 | 4 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Major prion protein | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 3 | 1 | 4 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
D | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 4 subunit alpha | 0 | 3 | 0 | 4 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 4 | 1 | 0 | 5 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Envelope glycoprotein | 0 | 0 | 1 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 9 subunit alpha | 0 | 3 | 0 | 3 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Transporter | 0 | 2 | 0 | 2 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Peptidylglycine alpha-amidating monooxygenase | 0 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
IDH1 | 4 | 0 | 0 | 4 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
acetylcholinesterase | 3 | 0 | 0 | 3 |
Fumarate hydratase | 2 | 0 | 0 | 2 |
polyprotein | 2 | 0 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1E | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
D | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
PINK1 | 1 | 0 | 0 | 1 |
Parkin | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Opioid receptor homologue | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
Delta-type opioid receptor | 0 | 1 | 0 | 2 |
Delta-type opioid receptor | 0 | 2 | 1 | 4 |
Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
Mu-type opioid receptor | 0 | 4 | 1 | 8 |
Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
Mu-type opioid receptor | 0 | 3 | 3 | 7 |
Delta-type opioid receptor | 0 | 3 | 2 | 6 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 3 | 2 | 6 |
Mu-type opioid receptor | 0 | 2 | 1 | 5 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 2 | 2 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | 0 | 1 | 0 | 1 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 0 | 1 | 0 | 1 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial | 0 | 1 | 0 | 1 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial | 0 | 1 | 0 | 1 |
Neuropeptide Y receptor type 1 | 0 | 2 | 0 | 2 |
Neuropeptide Y receptor type 2 | 0 | 2 | 0 | 2 |
DNA polymerase iota isoform a (long) | 2 | 0 | 0 | 2 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
Estrogen receptor | 0 | 0 | 1 | 1 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
Estrogen receptor beta | 0 | 0 | 1 | 1 |
10 kDa chaperonin | 0 | 2 | 0 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 4 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
endonuclease IV | 2 | 0 | 0 | 2 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
Vpr | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 1 | 2 |
Arylacetamide deacetylase | 0 | 1 | 0 | 2 |
Caspase-1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Substance-K receptor | 0 | 1 | 1 | 2 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Substance-P receptor | 0 | 2 | 1 | 3 |
Neuromedin-K receptor | 0 | 1 | 1 | 2 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Aurora kinase A | 0 | 1 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
ATP-dependent 6-phosphofructokinase | 0 | 1 | 0 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 2 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase D3 | 0 | 1 | 0 | 1 |
Protein kinase C gamma type | 0 | 1 | 0 | 1 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
Cathepsin B | 0 | 1 | 0 | 1 |
Protein kinase C alpha type | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
Protein kinase C eta type | 0 | 1 | 0 | 1 |
P2Y purinoceptor 2 | 0 | 1 | 1 | 2 |
Protein kinase C iota type | 0 | 1 | 0 | 1 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2X purinoceptor 2 | 0 | 1 | 1 | 2 |
P2X purinoceptor 4 | 0 | 0 | 1 | 1 |
P2X purinoceptor 5 | 0 | 0 | 1 | 1 |
P2X purinoceptor 6 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 4 | 0 | 0 | 1 | 1 |
NAD-dependent protein deacetylase HST2 | 0 | 1 | 0 | 1 |
P2X purinoceptor 3 | 0 | 0 | 1 | 1 |
DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 1 | 0 | 1 | 0 | 1 |
DNA primase | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Protein kinase C theta type | 0 | 1 | 0 | 1 |
Protein kinase C zeta type | 0 | 1 | 0 | 1 |
Protein kinase C delta type | 0 | 1 | 0 | 1 |
P2Y purinoceptor 6 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase D1 | 0 | 1 | 0 | 1 |
Dual specificity protein phosphatase 5 | 0 | 1 | 0 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 8 | 0 | 1 | 0 | 1 |
RmtA | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 3 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-2 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-1 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 11 | 0 | 1 | 1 | 2 |
P2X purinoceptor 7 | 0 | 0 | 1 | 1 |
Protein arginine N-methyltransferase 1 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 0 | 1 | 1 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine kinase, cytosolic | 0 | 2 | 0 | 4 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 2 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Sterol 14-alpha-demethylase | 0 | 0 | 1 | 1 |
14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 0 | 1 | 1 |
Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Cytochrome P450 144 | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Sterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
Cholesterol 24-hydroxylase | 0 | 2 | 1 | 3 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |